Core Viewpoint - The company Shengda Resources (000603.SZ) plans to acquire a 55% stake in Guangxi Jinshi for 269.5 million yuan to enhance its mineral resource reserves and ensure sustainable development [1] Group 1: Acquisition Details - The acquisition involves cash payment of 26,950,000 yuan for the stake held by four individuals: Jiang Wenli (25.003%), Liu Minchao (21.065%), Liu Xifeng (4.6475%), and Lu Qian (4.2845%) [1] - Upon completion of the transaction, Guangxi Jinshi will become a subsidiary of Shengda Resources [1] Group 2: Asset Overview - Guangxi Jinshi holds mining rights for three key mining assets located in Xiangzhou County, Laibin City, Guangxi: Miaohuang Copper-Lead-Zinc-Silver Mine, Huapeng-Na Yi Copper-Lead-Zinc-Silver Exploration Rights, and Huahou-Huayi Copper-Lead-Zinc-Silver Exploration Rights [1] - The mining rights will remain under Guangxi Jinshi's name post-transaction, and there will be no transfer of mining rights ownership, thus avoiding the need for related approval procedures [1]

Core Viewpoint - The company intends to acquire 90.02% equity of Chengdu Xinchao Media Group Co., Ltd. through a combination of share issuance and cash payment, involving 45 counterparties including Zhang Jixue [1] Group 1: Acquisition Details - The acquisition involves the issuance of shares and cash payment to purchase the equity from 45 counterparties [1] - The transaction is subject to approval from the Shenzhen Stock Exchange, registration consent from the China Securities Regulatory Commission, and antitrust review by the State Administration for Market Regulation [1] - The timeline and certainty of the approvals are currently unknown [1]

Group 1 - The company announced the issuance of 354 million yuan of convertible bonds, with a net fundraising amount of 346 million yuan and a maturity of 6 years [1] - The initial conversion price for the bonds is set at 24.38 yuan per share [1] - The company acquired a 34% stake in Yunbianyun for 83.3 million yuan, and its wholly-owned subsidiary Hefei Haohan purchased a 5% equity stake from the employee stock ownership platform for 2.45 million yuan, resulting in a total control of 54% voting rights [1] Group 2 - The total transaction price for the acquisitions is 85.75 million yuan, which will be paid in three installments [1] - The board of directors approved the proposal on January 7, 2026, and the agreement has been signed [1]

Core Viewpoint - LFG Investment Holdings (03938) experienced a significant stock price surge of over 120% following the announcement of a major share transfer involving its original major shareholder, Likao Financial Group [1] Group 1: Share Transfer Details - Likao Financial Group transferred a 61.43% stake, equivalent to 299 million shares, to an independent third party, Fortune Origin International Capital, for a total cash consideration of HKD 180 million, which translates to HKD 0.6 per share [1] - The completion of this transaction will require the buyer to make a mandatory general offer at the same cash price of HKD 0.6 per share, representing a discount of 59.46% compared to the last closing price before the suspension [1] Group 2: Buyer Information - The buyer, Fortune Origin International Capital, is engaged in investment holding and is wholly owned by Chen Shaoyang, who is also the sole director of the buyer [1] - The buyer intends to maintain the listing status of the shares post-acquisition [1]

Core Viewpoint - Shanghai Rongtai Health Technology Co., Ltd. plans to acquire 21% equity in Shanghai Youmo Youyang Health Technology Co., Ltd. for 42 million yuan, which will allow the company to control 56.50% of the voting rights post-transaction, thus making it a subsidiary [2][4][11]. Group 1: Transaction Overview - The company intends to purchase 21% equity from shareholders of Youmo Youyang, with a total transaction price based on an asset valuation of 210.08 million yuan [4][15]. - The transaction has been approved by the company's board and does not require shareholder approval [3][40]. - The transaction is classified as a related party transaction due to the agreement with a shareholder, Zeng Biyan [2][4]. Group 2: Financial and Operational Impact - The acquisition is expected to enhance the company's competitive edge in the small massage appliance market, which is less affected by economic cycles [12][37]. - Youmo Youyang has shown significant growth potential, with its profitability improving in 2025 compared to 2024, indicating a strong financial outlook [13][38]. - The transaction will allow the company to consolidate its financials, improving revenue and profitability metrics [13][38]. Group 3: Valuation and Pricing - The valuation of Youmo Youyang was conducted using both asset-based and income approaches, with the latter deemed more reflective of the company's value due to its unique market position [16][18]. - The assessed market value of Youmo Youyang was 210.08 million yuan, with an appreciation of 171.52 million yuan, resulting in a valuation increase rate of 444.88% [16][19]. Group 4: Governance and Control - Post-transaction, the company will appoint three directors to Youmo Youyang's board, ensuring a 50% representation [11]. - The agreement with Zeng Biyan ensures aligned voting in shareholder meetings, solidifying control over Youmo Youyang [27][29]. Group 5: Compliance and Approval - The transaction has been reviewed and approved by the independent directors and the board, adhering to relevant regulations [40]. - No prior related transactions occurred between the company and the transaction parties in the last 12 months [3][40].

格隆汇1月9日丨荣泰健康(603579.SH)公布，公司基于对未来战略布局、协同发展以及市场竞争力提升 的需求，于2025年11月28日召开第五届董事会第三次会议，审议通过了《关于筹划收购参股公司部分股 权并签订意向协议的议案》，公司拟收购厦门市蒙泰健康科技有限公司、宁波富爵电子科技有限公司、 曾必焱、王坤、王健持有的有摩有样21%股权，具体内容详见公司于2025年12月2日披露的《关于筹划 收购参股公司部分股权并签署意向协议的提示性公告》（公告编号：2025-083）。近期，本次交易所涉 及的尽职调查、审计、评估等事项已完成，根据交易各方协商一致并结合天源资产评估有限公司出具 的"天源评报字（2026）第0002号"资产评估报告，本次交易价格以评估基准日2025年9月30日，标的公 司全部股东权益价值的评估值21,008万元为基础，公司本次拟购买标的公司21%股权对应的交易价格为 4,200万元。同时，公司与标的公司交易对方曾必焱签订一致行动人协议，通过一致行动协议及相关治 理安排，在本次交易完成后公司合计控制标的公司56.50%表决权，取得标的公司的控制权。本次交易 完成后，标的公司将纳入公司合并报表范围 ...

内蒙华电公告称，公司拟发行股份及支付现金，向北方公司购买北方上都正蓝旗新能源70%股权与北方 多伦新能源75.51%股权。2025年12月31日，公司获证监会相关批复。本次权益变动后，北方公司及其 一致行动人持股比例由53.23%增至58.18%，权益变动比例触及5%刻度整数倍。本次变动不会导致公司 控股股东及实际控制人变更，符合免于发出要约规定，不影响公司上市地位。 ...

Core Viewpoint - Hualan Co., Ltd. has signed a share transfer agreement to acquire a 35% stake in Ningbo Guangfeng Capsule Co., Ltd. from Ningbo Spokan Biotechnology Co., Ltd. for RMB 8.4647 million, with plans to increase its ownership to between 51% and 70% by 2028 [1] Group 1 - Hualan Co., Ltd. will use its own funds to purchase a 35% stake in Guangfeng Capsule, with the transaction expected to enhance its control over the company [1] - The agreement allows Hualan to further acquire an additional 16% to 35% of Guangfeng's shares between 2026 and 2028, potentially increasing its stake to a controlling interest [1] - Guangfeng Capsule specializes in the manufacturing and sales of hollow capsules, with its core product, gelatin hollow capsules, having passed technical review by the National Medical Products Administration [1] Group 2 - The completion of this transaction will enable Hualan to share customer resources with Guangfeng, leveraging its compliance management capabilities and quality control systems to enhance product quality and expand business scale [1]

江苏懿德为于中国成立的有限责任公司，主要于中国从事股权投资及物业租赁业务。集团主要从事住宅 及商业房地产业务。鉴于懿德物业所在地段优越，董事会拟透过江苏懿德持有懿德物业作投资用途，并 从中获取租金收入。董事会认为，以相对具竞争力的价格收购懿德物业以获得潜在资本增值及未来租金 收入来源，对集团而言实属有利之举。于本公告日期，大部分懿德物业已出租予独立第三方。懿德物业 租约的每年总租金收入约为人民币780万元，相应的租金回报率约为5.97%。考虑到懿德物业的地段优 势，集团认为收购事项(即透过收购江苏懿德全部股权取得懿德物业)有望优化集团的收益基础与资产结 构。集团亦认为，收购事项将带来更佳现金流前景、潜在资本增值空间及未来更高回报。 智通财经APP讯，美瑞健康国际(02327)发布公告，于2026年1月8日，公司(作为买方)拟向宇业集团及谈 文生女士(作为卖方)收购江苏懿德的全部股权，总代价为人民币1.25亿元。同日，周旭洲先生(作为担保 人)签署了一份担保契据，向公司提供个人担保，以保证卖方履行股权转让协议项下的义务。收购事项 完成后，公司将持有江苏懿德的全部股权。因此，江苏懿德将成为公司的全资附属公司，其财 ...

Stjórn Skaga hefur tekið ákvörðun um að nýta kauprétt á alls 14,1% hlut í Íslenskum verðbréfum hf. („félagið“) af minnihlutaeigendum félagsins, sbr. tilkynningu Skaga þann 16. desember 2024. Kaupverðið reiknast út frá því að heildarvirði hluta sé 1,5% af eignum í stýringu félagsins þann 31. desember 2025. Gert er ráð fyrir að seljendur hlutanna fái kaupverðið greitt með 24.231.800 nýjum hlutum í Skaga sem lúta sölubanni til tveggja ára. Fjöldi hluta er reiknaður út frá meðalgengi hlutabréfa Skaga eins og þa ...